Published in
American Association for the Advancement of Science, Science Translational Medicine, 524(12), 2020
DOI: 10.1126/scitranslmed.aax7533
Links
Tools
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
Journal article published in 2020 by
Huiyan Luo 
,
Qi Zhao ,
Wei Wei ,
Lianghong Zheng ,
Shaohua Yi ,
Gen Li,
Wenqiu Wang,
Hui Sheng,
Hengying Pu,
Haiyu Mo,
Zhixiang Zuo ,
Zexian Liu ,
Chaofeng Li,
Chuanbo Xie,
Zhaolei Zeng
and other authors.
,
Qi Zhao ,
Wei Wei ,
Lianghong Zheng ,
Shaohua Yi ,
Gen Li,
Wenqiu Wang,
Hui Sheng,
Hengying Pu,
Haiyu Mo,
Zhixiang Zuo ,
Zexian Liu ,
Chaofeng Li,
Chuanbo Xie,
Zhaolei Zeng
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Circulating tumor DNA methylation–based signatures are potential biomarkers for early diagnosis and prognosis of colorectal cancer.